Pfizer (PFE)

44.50 +0.50 (1.14%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/30/18 *Est.)

Latest Headlines

Pfizer Presents Overall Survival Data From PALOMA-3 Trial of IBRANCE® (palbociclib) in Patients With HR+, HER2- Metastatic Breast Cancer October 20, 2018 10:30 AM - BizWire Merck (MRK) Reports Significant Improved OS & PFS Data from Pivotal Phase 3 KEYNOTE-426 Trial Investigating KEYTRUDA (pembrolizumab) in Combination with Pfizer’s (PFE) Inlyta (axitinib) October 18, 2018 7:01 AM - StreetInsider Pfizer to cut around 2 percent of jobs through early next year October 17, 2018 1:02 PM - StreetInsider Pfizer (PFE) offers early retirement ahead of layoffs in memo to employees - CNBC October 17, 2018 11:22 AM - StreetInsider Pfizer (PFE) PT Raised to $53 at Cantor Fitzgerald October 17, 2018 9:06 AM - StreetInsider Form 4 PFIZER INC For: Oct 15 Filed by: YOUNG JOHN D October 16, 2018 6:44 PM - SEC Filing Form 4 PFIZER INC For: Oct 15 Filed by: ROGERS DAWN October 16, 2018 6:44 PM - SEC Filing Form 4 PFIZER INC For: Oct 15 Filed by: JOHNSON RADY A October 16, 2018 6:44 PM - SEC Filing Form 4 PFIZER INC For: Oct 15 Filed by: BOURLA ALBERT October 16, 2018 6:44 PM - SEC Filing BioMarin Pharma (BMRN) Announces $15M Milestone Payment from Pfizer (PFE) October 16, 2018 12:59 PM - StreetInsider FDA approves Pfizer's (PFE) talazoparib for gBRCAm HER2-negative locally advanced or metastatic breast cancer October 16, 2018 11:28 AM - StreetInsider U.S. to propose TV ads for drugs must include list prices October 15, 2018 1:37 PM - StreetInsider Form 4 PFIZER INC For: Oct 09 Filed by: YOUNG JOHN D October 10, 2018 5:48 PM - SEC Filing Form 4 PFIZER INC For: Oct 09 Filed by: JOHNSON RADY A October 10, 2018 5:47 PM - SEC Filing Form 4 PFIZER INC For: Oct 09 Filed by: ROGERS DAWN October 10, 2018 5:47 PM - SEC Filing Form 4 PFIZER INC For: Oct 09 Filed by: BOURLA ALBERT October 10, 2018 5:47 PM - SEC Filing Increasing unusual option volume: PFE NIO CCK GE IMPV ACRX ITT FAST ACHC EWH ESPR NIO October 10, 2018 11:42 AM - StreetInsider Pfizer Announces Executive Leadership Team October 9, 2018 9:05 AM - BizWire Myriad Genetics (MYGN) announces it signed commercialization plan with Pfizer (PFE) October 9, 2018 7:15 AM - StreetInsider Stada, buyout funds in race for Bristol-Myers' French business: sources October 8, 2018 9:16 AM - StreetInsider Form 4 PFIZER INC For: Sep 28 Filed by: JOHNSON RADY A October 1, 2018 5:32 PM - SEC Filing Form 4 PFIZER INC For: Sep 28 Filed by: YOUNG JOHN D October 1, 2018 5:32 PM - SEC Filing Form 4 PFIZER INC For: Sep 28 Filed by: ROGERS DAWN October 1, 2018 5:32 PM - SEC Filing Form 4 PFIZER INC For: Sep 28 Filed by: BOURLA ALBERT October 1, 2018 5:32 PM - SEC Filing Form 8-K PFIZER INC For: Sep 27 October 1, 2018 4:55 PM - SEC Filing Form 4 PFIZER INC For: Sep 28 Filed by: NARAYEN SHANTANU October 1, 2018 4:21 PM - SEC Filing Form 4 PFIZER INC For: Sep 28 Filed by: SMITH JAMES C October 1, 2018 4:21 PM - SEC Filing Form 4 PFIZER INC For: Sep 28 Filed by: KILTS JAMES M October 1, 2018 4:21 PM - SEC Filing Form 4 PFIZER INC For: Sep 28 Filed by: Echevarria Joseph October 1, 2018 4:21 PM - SEC Filing Pfizer to replace longtime CEO Read with veteran Bourla October 1, 2018 6:51 AM - StreetInsider Pfizer (PFE) Elected Dr. Albert Bourla to Succeed Ian Read as CEO Effective January 1; Ian Read will Transition to Executive Chairman October 1, 2018 6:46 AM - StreetInsider Pfizer Announces CEO Succession October 1, 2018 6:45 AM - BizWire Pfizer (PFE) COO Albert Bourla to become CEO; Read to shift to Executive Chairman - WSJ October 1, 2018 6:40 AM - StreetInsider Scientists behind game-changing cancer immunotherapies win Nobel medicine prize October 1, 2018 5:43 AM - StreetInsider Pfizer (PFE) Announces U.S. FDA Approval of VIZIMPRO for First-Line Treatment of Patients with EGFR-Mutated Metastatic NSCLC September 27, 2018 5:42 PM - StreetInsider U.S. FDA Approves VIZIMPRO® (dacomitinib) for the First-Line Treatment of Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer September 27, 2018 5:41 PM - BizWire Pfizer (PFE) Declares $0.34 Quarterly Dividend; 3.1% Yield September 27, 2018 1:12 PM - StreetInsider Pfizer Declares 34-Cent Fourth-Quarter 2018 Dividend September 27, 2018 1:09 PM - BizWire Amarin Corp. (AMRN) Ticks Higher on Renewed Takeover Chateter September 27, 2018 9:42 AM - StreetInsider Pfizer AA Data is a Positive Read Through to CTP-543 - Mizuho (PFE) (CNCE) September 24, 2018 9:17 AM - StreetInsider Astellas Receives Positive CHMP Opinion for XTANDI® (enzalutamide) for Adult Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer September 24, 2018 9:00 AM - PR NewsWire Sarepta Therapeutics (SRPT) and Pfizer (PFE) Could Make Headlines At The World Muscle Society Conference - Nomura September 24, 2018 6:27 AM - StreetInsider Animal health firm Elanco surges 41 percent on debut September 20, 2018 11:41 AM - StreetInsider Pfizer (PFE) Granted FDA Breakthrough Therapy Designation for 20-Valent Pneumococcal Conjugate Vaccine for Prevention of Invasive Disease and Pneumonia in Adults September 20, 2018 8:05 AM - StreetInsider Pfizer Granted FDA Breakthrough Therapy Designation for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older September 20, 2018 8:00 AM - BizWire Pfizer Invites Public to View and Listen to Webcast of October 30 Conference Call with Analysts September 19, 2018 4:26 PM - BizWire New Sub-group Analyses from the Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Presented at 2018 HFSA Annual Scientific Meeting September 19, 2018 4:26 PM - BizWire New Sub-group Analyses from the Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Presented at 2018 HFSA Annual Scientific Meeting September 18, 2018 2:45 PM - BizWire Pfizer Invites Public to View and Listen to Webcast of October 30 Conference Call with Analysts September 18, 2018 10:00 AM - BizWire Pfizer (PFE) Says New Sub-group Analyses from Tafamidis Phase 3 ATTR-ACT Study Presented at HFSA September 18, 2018 9:04 AM - StreetInsider New Sub-group Analyses from the Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Presented at 2018 HFSA Annual Scientific Meeting September 18, 2018 9:01 AM - BizWire Form 4 PFIZER INC For: Sep 13 Filed by: Dolsten Mikael September 17, 2018 4:13 PM - SEC Filing Form 4 PFIZER INC For: Sep 14 Filed by: YOUNG JOHN D September 17, 2018 4:12 PM - SEC Filing Form 4 PFIZER INC For: Sep 14 Filed by: JOHNSON RADY A September 17, 2018 4:12 PM - SEC Filing Form 4 PFIZER INC For: Sep 14 Filed by: BOURLA ALBERT September 17, 2018 4:11 PM - SEC Filing Form 4 PFIZER INC For: Sep 14 Filed by: ROGERS DAWN September 17, 2018 4:11 PM - SEC Filing Pfizer (PFE) Announces Evaluation Agreement with Atomwise Inc. September 17, 2018 8:10 AM - StreetInsider Atomwise Enters Into an Evaluation Agreement with Pfizer September 17, 2018 8:01 AM - BizWire Pfizer (PFE) Announces Positive Phase 2 Data in Alopecia Areata at 2018 EADV Congress September 17, 2018 5:50 AM - StreetInsider Pfizer Presents Positive Phase 2 Data in Alopecia Areata During Late-Breaker Session at the 27th European Academy of Dermatology and Venereology (EADV) Congress September 15, 2018 2:00 AM - BizWire Roche steps up efficiency drive to take sting out of biosimilars September 13, 2018 12:49 PM - StreetInsider Mylan N.V. (MYL) Gains on Chatter September 13, 2018 9:49 AM - StreetInsider BAVENCIO® (avelumab) Plus INLYTA® (axitinib) Significantly Improved Progression-Free Survival in Previously Untreated Patients With Advanced Renal Cell Carcinoma in Phase III Study September 11, 2018 8:28 AM - PR NewsWire Expert Call Increases Confidence In The Acceleration Of Pfizer's (PFE) ATTRCM Diagnosis Rate - BMO September 10, 2018 8:25 AM - StreetInsider Form 8-K PFIZER INC For: Sep 04 September 7, 2018 5:12 PM - SEC Filing Form 424B5 PFIZER INC September 6, 2018 5:02 PM - SEC Filing Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference September 6, 2018 11:30 AM - BizWire Pfizer (PFE) PT Raised to $48 at Cowen September 6, 2018 10:50 AM - StreetInsider Pfizer (PFE) PT Raised to $47 at BMO Capital; Sees Tafamidis as a $3.5B+ Drug September 6, 2018 8:27 AM - StreetInsider Pfizer (PFE) Gains FDA Breakthrough Therapy Designation for PF-06651600 September 5, 2018 8:51 AM - StreetInsider Pfizer Receives Breakthrough Therapy Designation from FDA for PF-06651600, an oral JAK3 Inhibitor, for the Treatment of Patients with Alopecia Areata September 5, 2018 8:50 AM - BizWire Form FWP PFIZER INC Filed by: PFIZER INC September 5, 2018 6:07 AM - SEC Filing Pfizer Prices $5,000,000,000 Debt Offering September 4, 2018 8:38 PM - BizWire Form 4 PFIZER INC For: Aug 31 Filed by: JOHNSON RADY A September 4, 2018 5:31 PM - SEC Filing Form 4 PFIZER INC For: Aug 31 Filed by: YOUNG JOHN D September 4, 2018 5:31 PM - SEC Filing Form 4 PFIZER INC For: Aug 31 Filed by: ROGERS DAWN September 4, 2018 5:30 PM - SEC Filing Form 4 PFIZER INC For: Aug 31 Filed by: BOURLA ALBERT September 4, 2018 5:30 PM - SEC Filing Form 424B3 PFIZER INC September 4, 2018 8:19 AM - SEC Filing With drugs pipeline in focus, Bayer considers job cuts: source September 4, 2018 7:08 AM - StreetInsider Pfizer (PFE) Terminates Domagrozumab Clinical Studies for the Treatment of DMD August 30, 2018 8:00 AM - StreetInsider Pfizer Terminates Domagrozumab (PF-06252616) Clinical Studies for the Treatment of Duchenne Muscular Dystrophy August 30, 2018 8:00 AM - BizWire Pfizer, Inc. (PFE) Issues A Voluntary Nationwide Recall Of One Lot Of Children’s Advil Suspension Bubble Gum Flavored 4 FL OZ Bottle August 28, 2018 11:21 AM - StreetInsider Pfizer (PFE) PT Raised to $45 at Goldman Sachs August 28, 2018 7:48 AM - StreetInsider Pfizer (PFE) Says Too Early To Comment on U.S. Pricing for Tafamidis -Bloomberg August 27, 2018 9:23 AM - StreetInsider Pfizer (PFE) Reports Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Results at ESC Congress 2018 August 27, 2018 5:40 AM - StreetInsider Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Results Presented as Late-Breaking Data at the ESC Congress 2018 August 27, 2018 5:21 AM - BizWire Pfizer (PFE) PT Raised to $45 at Morgan Stanley August 23, 2018 6:52 AM - StreetInsider Pfizer (PFE) PT Raised to $40 at Barclays August 23, 2018 4:44 AM - StreetInsider Pfizer (PFE), Astellas Pharma Inc. Reports Amendments to Clinical Research Protocols for Two Phase 3 Trials of Enzalutamide August 22, 2018 5:01 PM - StreetInsider Pfizer and Astellas Amend Clinical Research Protocols for Two Phase 3 Trials of Enzalutamide in Patients with Hormone-Sensitive Prostate Cancer August 22, 2018 5:00 PM - PR NewsWire Pfizer and Astellas Amend Clinical Research Protocols for Two Phase 3 Trials of Enzalutamide in Patients with Hormone-Sensitive Prostate Cancer August 22, 2018 5:00 PM - BizWire Exclusive: Pharma sector warns Saudis on German drug curbs August 22, 2018 10:29 AM - StreetInsider Pre-Open Movers 8/22: (EXAS) (NEWA) (LZB) Higher; (SMCI) (NBEV) (GSM) Lower (more...) August 22, 2018 9:26 AM - StreetInsider Exact Sciences (EXAS) Set to Open Higher by 20% Following Promotional Agreement with Pfizer (PFE) for Cologuard August 22, 2018 8:42 AM - StreetInsider Exact Sciences (EXAS) Announces U.S. Promotional Agreement with Pfizer (PFE) for Cologuard August 22, 2018 6:09 AM - StreetInsider Exact Sciences and Pfizer Enter into U.S. Promotion Agreement for Cologuard® August 22, 2018 6:00 AM - PR NewsWire Deutsche Bank Raises Pfizer (PFE) PT Prior To tafamidis Data August 21, 2018 6:30 AM - StreetInsider Pfizer Invites Public to View and Listen to Webcast of August 27 Conference Call with Analysts and Investors to Review Tafamidis Data Presentation at ESC Congress 2018 August 20, 2018 10:00 AM - BizWire U.S. health secretary says agency can eliminate drug rebates August 20, 2018 7:06 AM - StreetInsider Form 4 PFIZER INC For: Aug 15 Filed by: YOUNG JOHN D August 16, 2018 9:23 PM - SEC Filing Form 4 PFIZER INC For: Aug 15 Filed by: JOHNSON RADY A August 16, 2018 9:23 PM - SEC Filing Form 4 PFIZER INC For: Aug 15 Filed by: ROGERS DAWN August 16, 2018 9:23 PM - SEC Filing Form 4 PFIZER INC For: Aug 15 Filed by: BOURLA ALBERT August 16, 2018 9:23 PM - SEC Filing Pfizer (PFE) Reports Collaboration Agreement with BioNTech for Development mRNA-based Vaccines for Prevention of Influenza August 16, 2018 6:08 AM - StreetInsider BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza August 16, 2018 6:00 AM - BizWire BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza August 16, 2018 1:00 AM - BizWire Form 4 PFIZER INC For: Aug 13 Filed by: Dolsten Mikael August 14, 2018 5:06 PM - SEC Filing Form 4 PFIZER INC For: Aug 13 Filed by: OLSON LAURIE J August 14, 2018 5:06 PM - SEC Filing UPDATE: Goldman Sachs Downgrades Alnylam Pharmaceuticals (ALNY) to Buy August 13, 2018 3:25 AM - StreetInsider Form 10-Q PFIZER INC For: Jul 01 August 9, 2018 4:34 PM - SEC Filing Pfizer (PFE) Cannot Guarantee Epipen Availability in all Pharmacies - Bloomberg August 8, 2018 10:29 AM - StreetInsider Affimed Reports Financial Results for Second Quarter 2018 and Operational Progress August 8, 2018 7:32 AM - StreetInsider Trump says will make announcement next week on reducing drug prices August 7, 2018 8:15 PM - StreetInsider Pfizer (PFE) PT Raised to $34 at Citi August 7, 2018 7:02 AM - StreetInsider Gemphire Therapeutics (GEMP) Announces Amended, Restated Gemcabene License Agreement with Pfizer (PFE) August 6, 2018 4:02 PM - StreetInsider Form 4 PFIZER INC For: Aug 03 Filed by: MACKENZIE ALEXANDER R August 6, 2018 3:20 PM - SEC Filing Antares Pharma (ATRS) Enters Agreement with Pfizer (PFE) to Develop Drug Device Rescue Pen August 6, 2018 7:06 AM - StreetInsider Form 4 PFIZER INC For: Aug 01 Filed by: GOETTLER MICHAEL August 3, 2018 3:39 PM - SEC Filing Form 4 PFIZER INC For: Aug 01 Filed by: CANGIALOSI LORETTA V August 3, 2018 3:37 PM - SEC Filing Form 4 PFIZER INC For: Aug 01 Filed by: LUND-JURGENSEN KIRSTEN August 3, 2018 3:36 PM - SEC Filing Form 4 PFIZER INC For: Aug 01 Filed by: DAMELIO FRANK A August 3, 2018 3:34 PM - SEC Filing U.S. tax cuts prompt rethink by some 'inverted' companies August 3, 2018 3:24 PM - StreetInsider Form 4 PFIZER INC For: Jul 31 Filed by: YOUNG JOHN D August 2, 2018 3:58 PM - SEC Filing Form 4 PFIZER INC For: Jul 31 Filed by: JOHNSON RADY A August 2, 2018 3:58 PM - SEC Filing Form 4 PFIZER INC For: Jul 31 Filed by: ROGERS DAWN August 2, 2018 3:58 PM - SEC Filing Form 4 PFIZER INC For: Jul 31 Filed by: BOURLA ALBERT August 2, 2018 3:58 PM - SEC Filing Pfizer (PFE) Reports Marketing Authorization in European Union from Euro Commission for Moderately to Severely Active Ulcerative Colitis August 1, 2018 6:30 AM - StreetInsider Popular stocks with increasing unusual option volume: QCOM PFE PBR August 1, 2018 5:12 AM - StreetInsider XELJANZ® (tofacitinib citrate) Receives Marketing Authorization in the European Union for Moderately to Severely Active Ulcerative Colitis August 1, 2018 1:00 AM - BizWire Pfizer (PFE) Would Look to Tuck-In Gene Therapy Deals if Price is Right - Bloomberg, Citing Comments on Call July 31, 2018 10:51 AM - StreetInsider Form 8-K PFIZER INC For: Jul 31 July 31, 2018 8:56 AM - SEC Filing Wall St. bounces back, led by industrials July 31, 2018 7:50 AM - StreetInsider Pfizer CEO expects Trump to eliminate drug rebates July 31, 2018 7:00 AM - StreetInsider Pfizer (PFE) Tops Q2 EPS by 7c, Updates Guidance July 31, 2018 6:46 AM - StreetInsider PFIZER REPORTS SECOND-QUARTER 2018 RESULTS July 31, 2018 6:45 AM - BizWire Pfizer (PFE) Announces EU Approval of Biosimilar TRAZIMERA July 31, 2018 6:10 AM - StreetInsider Pfizer Receives European Approval for Oncology Biosimilar, TRAZIMERA™ (trastuzumab) July 31, 2018 6:00 AM - BizWire Pfizer's New Report Shows How Behavioural Science Can Help Boost Preventative Healthcare Measures July 31, 2018 3:00 AM - PR NewsWire Merck profit beats, but Keytruda sales fail to impress July 27, 2018 6:57 AM - StreetInsider Pharma's middlemen see shares suffer as challenges grow July 25, 2018 12:04 PM - StreetInsider Pfizer (PFE) to Build Sterile Injectable Facility in Michigan July 24, 2018 1:31 PM - StreetInsider Pfizer to Build Cutting-Edge Sterile Injectable Facility in Michigan, Investing Nearly Half a Billion Dollars in U.S. Manufacturing, Creating More than 450 Jobs July 24, 2018 1:30 PM - BizWire Form 4 PFIZER INC For: Jul 20 Filed by: SUSMAN SALLY July 24, 2018 1:10 PM - SEC Filing Pfizer (PFE), GlaxoSmithKline Company ViiV Healthcare Announces SWORD 100-Week Data for Juluca (dolutegravir/rilpivirine) at AIDS 2018 July 24, 2018 5:54 AM - StreetInsider Pfizer (PFE), GlaxoSmithKline Company ViiV Healthcare Highlights Phase III Data at AIDS 2018 July 24, 2018 5:49 AM - StreetInsider ViiV Healthcare announces SWORD 100-week data for Juluca (dolutegravir/rilpivirine) at AIDS 2018 July 24, 2018 5:38 AM - BizWire ViiV Healthcare Presents Phase III Data at AIDS 2018 from Landmark GEMINI Studies Showing Two-Drug Regimen of Dolutegravir and Lamivudine Has Similar Efficacy to a Three-Drug Regimen in Treatment Naï July 24, 2018 5:35 AM - BizWire Full Article List